Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 2 |
2006 | 3 |
2007 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17414-9. doi: 10.1073/pnas.0605136103. Epub 2006 Nov 6.
Proc Natl Acad Sci U S A. 2006.
PMID: 17088564
Free PMC article.
Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.
Azam P, Sankaranarayanan A, Homerick D, Griffey S, Wulff H.
Azam P, et al. Among authors: homerick d.
J Invest Dermatol. 2007 Jun;127(6):1419-29. doi: 10.1038/sj.jid.5700717. Epub 2007 Feb 1.
J Invest Dermatol. 2007.
PMID: 17273162
Free PMC article.
Item in Clipboard
Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain.
Mouhat S, Teodorescu G, Homerick D, Visan V, Wulff H, Wu Y, Grissmer S, Darbon H, De Waard M, Sabatier JM.
Mouhat S, et al. Among authors: homerick d.
Mol Pharmacol. 2006 Jan;69(1):354-62. doi: 10.1124/mol.105.017210. Epub 2005 Oct 18.
Mol Pharmacol. 2006.
PMID: 16234482
Item in Clipboard
A new class of blockers of the voltage-gated potassium channel Kv1.3 via modification of the 4- or 7-position of khellinone.
Harvey AJ, Baell JB, Toovey N, Homerick D, Wulff H.
Harvey AJ, et al. Among authors: homerick d.
J Med Chem. 2006 Feb 23;49(4):1433-41. doi: 10.1021/jm050839v.
J Med Chem. 2006.
PMID: 16480279
Item in Clipboard
Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.
Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D, Hänsel W, Wulff H.
Schmitz A, et al. Among authors: homerick d.
Mol Pharmacol. 2005 Nov;68(5):1254-70. doi: 10.1124/mol.105.015669. Epub 2005 Aug 11.
Mol Pharmacol. 2005.
PMID: 16099841
Item in Clipboard
Cite
Cite